CKD Bio Corp operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CKD Bio Corp with three other
companies in this sector in KOREA (SOUTH) :
Ctc Bio, Incorporation.
sales of 136.12 billion Korean Won [US$123.19 million]
of which 80%
was Animal Medication),
Samil Pharmaceutical Co., Ltd.
(121.11 billion Korean Won [US$109.60 million]
Kolon Life Science Incorporation
(148.54 billion Korean Won [US$134.43 million]
of which 98%
CKD Bio Corp reported sales of 137.18 billion Korean Won (US$124.15 million)
December of 2019.
increase of 10.2%
versus 2018, when the company's sales were 124.51 billion Korean Won .
Sales at CKD Bio Corp have increased during each of the previous five years
(and since 2014, sales have increased a total of 29%).